GlassScriptPhysician profile
Thomas Jacob Chambers
NPI 1295049609
$1,118.09
in general payments reported to CMS, 2019-2025
14 companies · $76.00 in 2025
The $76.00 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $333 · 2020: $37.01 · 2021: $83.40 · 2022: $186 · 2023: $20.86 · 2024: $382 · 2025: $76.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $264 · Travel and Lodging: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $263.69 |
| Travel and Lodging | $215.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $364.81 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Treace Medical Concepts, INC. | $329.30 | 2019 | |
| Orthofix Medical, INC. | $83.09 | 2019-2024 | Physio-Stim |
| Stryker Corporation | $60.38 | 2021-2022 | |
| Biowound Solutions, INC. | $49.48 | 2025 | Bio-Connekt |
| Organogenesis INC. | $47.09 | 2020-2021 | |
| Biotissue Holdings INC. | $43.16 | 2022 | |
| Globus Medical, INC. | $26.52 | 2025 | Senza |
| Nevro Corp. | $25.54 | 2022 | |
| Djo, LLC | $23.49 | 2022 | |
| Medtronic, INC. | $20.86 | 2023 | Intellis Adaptivestim |
| Paratek Pharmaceuticals, INC. | $19.48 | 2022 | |
| Smith+Nephew, INC. | $12.65 | 2022 | |
| Next Science LLC | $12.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Chambers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.